Literature DB >> 893249

Mecillinam serum levels following intravenous injection: a comparison with pivmecillinam.

M Mitchard, J Andrews, M J Kendall, R Wise.   

Abstract

Serum mecillinam concentrations have been obtained in 6 volunteers after intravenous injection of 200 mg mecillinam and two 200 mg tablets containing pivmecillinam hydrochloride. Initial concentrations were between 6 and 9 mg/1 and peak concentrations of about 2-0 mg/1 occurred at 1 to 1-5 h after the tablets. Analysis of the intravenous data shows the concentration/time curve to be biphasic and similar to that previously reported for penicillin G. The biexponential curves describing the data have been calculated using nonlin. Comparison of the areas under the serum mecillinam concentration/time curves suggests a bioavailability of 65 to 70% for the tablets. However, the two preparations contain therapeutically equivalent amounts of antibiotic, as two 200 mg tablets of pivmecillinam contain 30% more mecillinam than the 200 mg injection.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 893249     DOI: 10.1093/jac/3.suppl_b.83

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Mecillinam in urinary tract infections and in septicaemia.

Authors:  N Frimodt-Møller; T J Ravn
Journal:  Infection       Date:  1979       Impact factor: 3.553

2.  Mecillinam in patients on haemodialysis.

Authors:  K Bailey; J G Cruickshank; P G Bisson; B L Radford
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

3.  Pharmacokinetics of bacmecillinam and pivmecillinam in volunteers.

Authors:  K Josefsson; T Bergan; L Magni; B G Pring; D Westerlund
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Pharmacokinetics of intravenous amdinocillin in healthy subjects and patients with renal insufficiency.

Authors:  I H Patel; L D Bornemann; V M Brocks; L S Fang; N E Tolkoff-Rubin; R H Rubin
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

5.  Single-dose kinetics and dosage of mecillinam in renal failure and haemodialysis.

Authors:  A Schapira
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

6.  Pharmacokinetics of mecillinam in health subjects.

Authors:  J G Gambertoglio; S L Barriere; E T Lin; J E Conte
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.